Judy A Alonzo, MD
Pathology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 7
Offices
7 locations · Peninsula Pathologists Medical Group Inc · 17 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Mills-Peninsula Medical Center · Novato Community Hospital · Sequoia Hospital · Sutter Coast Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alonzo’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G79181 · Current
Licensed to practise in California · since 1994 · expires 2028-03-31 · University of Colorado School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Coast HospitalCrescent City, CAAcute Care Hospital · Government - Hospital District or Authority · No emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 65% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Coast Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 1 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.02) · 178 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.5 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15.8 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 43 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 416 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,503 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,449 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.27 (1.84 to 6.7) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.21 (0.52 to 3.91) · 263 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.33 (0 to 17.93) · 59 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.01 (1.73 to 10.29) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.38 (0 to 1.43) · 1,201 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 82 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.1 · 109 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.4 · 169 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 114 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.1 to 9.3) · 79 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (7.4 to 14.9) · 79 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.2 to 17.8) · 499 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 62 cases | No different | Jan 2024 – Dec 2024 |
What patients said (283 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 3 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$121,710
Medicare paid this office $121,710 for 1,469 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 243 | $31,383 | $70 |
| Pathology examination of tissue using a microscope, intermediate complexity | 325 | $16,711 | $33 |
| Immunologic analysis technique on serum (immunofixation) | 235 | $7,631 | $16 |
| Special stained specimen slides to examine tissue, each additional procedure | 66 | $7,531 | $25 |
| Protein measurement, serum | 361 | $6,649 | $16 |
See all 27 services
| Pathology examination of tissue using a microscope, intermediate complexity | 243 | $31,383 | $70 |
| Pathology examination of tissue using a microscope, intermediate complexity | 325 | $16,711 | $33 |
| Immunologic analysis technique on serum (immunofixation) | 235 | $7,631 | $16 |
| Special stained specimen slides to examine tissue, each additional procedure | 66 | $7,531 | $25 |
| Protein measurement, serum | 361 | $6,649 | $16 |
| Pathology examination of tissue using a microscope, moderately high complexity | 57 | $6,045 | $75 |
| Evaluation of fine needle aspirate with interpretation and report | 25 | $5,754 | $174 |
| Evaluation of fine needle aspirate with interpretation and report | 65 | $5,394 | $63 |
| Protein measurement, body fluid | 127 | $3,746 | $16 |
| Special stained specimen slides to examine tissue, initial procedure | 82 | $2,881 | $32 |
| Special stained specimen slides to examine tissue, initial procedure | 15 | $2,484 | $113 |
| Microscopic genetic analysis of tumor, manual | 27 | $2,443 | $38 |
| Evaluation of fine needle aspirate | 55 | $2,380 | $32 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 13 | $2,082 | $160 |
| Cell examination of specimen, selective cellular enhancement technique | 55 | $1,668 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 16 | $1,140 | $71 |
| Pathology cytologic examination of specimen during surgery, initial site | 18 | $1,124 | $56 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 33 | $1,102 | $16 |
| Pathology examination of tissue using a microscope, limited examination | 271 | $1,098 | $4 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 23 | $913 | $20 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 20 | $614 | $31 |
| Pathology examination of tissue using a microscope, moderately low complexity | 52 | $573 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $553 | $24 |
| Preparation of tissue for examination by removing any calcium present | 44 | $529 | $11 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 14 | $363 | $26 |
| Total protein level, urine | 74 | $284 | $4 |
| Pathology clinical consultation for clinical problem, 5-20 minutes | 11 | $222 | $20 |
Who their Medicare patients are
1,469 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 55% · Also on Medicaid 10% · Health risk score 1.22. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 70% · Chronic kidney disease 27% · Diabetes 26% · Coronary heart disease 26% · Atrial fibrillation 22% · Cancer 21% · Depression 18% · Heart failure 17% · COPD 11% · Stroke 6% · Dementia 5%.
The office billed $504,383, Medicare allowed $154,704 and paid $121,710; for 3,714 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,469 | 3,714 | 76 | 1.22 | $504,383 | $121,710 |
| 2023 | 1,383 | 2,928 | 75 | 1.15 | $560,934 | $133,428 |
| 2022 | 1,034 | 2,201 | 75 | 1.04 | $422,675 | $107,352 |
| 2021 | 1,049 | 2,353 | 75 | 1.10 | $336,753 | $90,308 |
| 2020 | 576 | 1,310 | 74 | 1.08 | $248,727 | $64,861 |
| 2019 | 1,892 | 3,686 | 74 | 1.23 | $763,653 | $193,556 |
| 2018 | 2,007 | 4,250 | 74 | 1.31 | $813,729 | $210,160 |
| 2017 | 1,884 | 3,765 | 74 | 1.34 | $720,169 | $183,547 |
| 2016 | 1,554 | 3,067 | 74 | 1.33 | $586,658 | $160,805 |
| 2015 | 1,504 | 3,073 | 73 | 1.17 | $727,470 | $197,735 |
| 2014 | 1,123 | 2,297 | 74 | 1.20 | $493,768 | $109,678 |
| 2013 | 577 | 1,087 | 77 | 1.77 | $55,903 | $22,848 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Pathology examination of tissue using a microscope, intermediate complexity | 411 | $57,937 | $68 |
| Pathology examination of tissue using a microscope, intermediate complexity | 262 | $14,372 | $33 |
| Evaluation of fine needle aspirate with interpretation and report | 42 | $9,731 | $168 |
| Special stained specimen slides to examine tissue, each additional procedure | 23 | $5,940 | $91 |
| Protein measurement, serum | 262 | $4,650 | $16 |
| Special stained specimen slides to examine tissue, initial procedure | 31 | $3,969 | $107 |
| Pathology examination of tissue using a microscope, moderately high complexity | 36 | $3,698 | $74 |
| Evaluation of fine needle aspirate with interpretation and report | 39 | $3,137 | $59 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 16 | $2,386 | $149 |
| Immunologic analysis technique on serum (immunofixation) | 75 | $2,086 | $16 |
| Special stained specimen slides to examine tissue, each additional procedure | 26 | $2,037 | $23 |
| Protein measurement, body fluid | 69 | $1,747 | $16 |
| Cell examination of specimen, selective cellular enhancement technique | 69 | $1,711 | $23 |
| Cell examination of specimen, selective cellular enhancement technique | 23 | $1,576 | $69 |
| Evaluation of fine needle aspirate | 38 | $1,541 | $30 |
| Special stained specimen slides to examine tissue, initial procedure | 34 | $1,276 | $30 |
| Pathology examination of tissue using a microscope, moderately low complexity | 12 | $648 | $46 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 22 | $642 | $29 |
| Pathology examination of tissue using a microscope, limited examination | 162 | $636 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $485 | $10 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 12 | $468 | $20 |
| Blood smear interpretation by physician with written report | 19 | $429 | $21 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 16 | $415 | $26 |
| Preparation of tissue for examination by removing any calcium present | 23 | $298 | $11 |
| Total protein level, urine | 61 | $230 | $4 |
| Pathology clinical consultation for clinical problem, 5-20 minutes | 12 | $219 | $18 |
2022: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 350 | $49,987 | $68 |
| Pathology examination of tissue using a microscope, intermediate complexity | 235 | $13,341 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 11 | $6,442 | $307 |
| Special stained specimen slides to examine tissue, each additional procedure | 31 | $3,907 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | $3,793 | $105 |
| Pathology examination of tissue using a microscope, moderately high complexity | 37 | $3,339 | $73 |
| Evaluation of fine needle aspirate with interpretation and report | 14 | $2,935 | $154 |
| Evaluation of fine needle aspirate with interpretation and report | 38 | $2,901 | $64 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,275 | $162 |
| Special stained specimen slides to examine tissue, initial procedure | 43 | $1,556 | $31 |
| Cell examination of specimen, selective cellular enhancement technique | 57 | $1,525 | $25 |
| Evaluation of fine needle aspirate | 32 | $1,308 | $33 |
| Protein measurement, serum | 65 | $1,084 | $16 |
| Pathology examination of tissue using a microscope, limited examination | 190 | $770 | $4 |
| Cell examination of specimen, selective cellular enhancement technique | 11 | $721 | $66 |
| Pathology examination of tissue using a microscope, moderately low complexity | 12 | $708 | $44 |
| Immunologic analysis technique on serum (immunofixation) | 34 | $635 | $16 |
| Pathology examination of tissue using a microscope, moderately low complexity | 33 | $385 | $10 |
| Protein measurement, body fluid | 21 | $362 | $16 |
| Preparation of tissue for examination by removing any calcium present | 22 | $285 | $11 |
2021: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 590 | $34,028 | $34 |
| Pathology examination of tissue using a microscope, intermediate complexity | 85 | $11,091 | $71 |
| Special stained specimen slides to examine tissue, each additional procedure | 60 | $7,479 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 62 | $7,242 | $78 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 36 | $5,890 | $164 |
| Special stained specimen slides to examine tissue, initial procedure | 113 | $4,406 | $33 |
| Evaluation of fine needle aspirate with interpretation and report | 54 | $4,164 | $66 |
| Cell examination of specimen, selective cellular enhancement technique | 106 | $3,089 | $26 |
| Evaluation of fine needle aspirate | 50 | $1,921 | $34 |
| Microscopic genetic analysis of tumor, manual | 21 | $1,889 | $39 |
| Pathology examination of tissue using a microscope, high complexity | 11 | $1,515 | $138 |
| Preparation of tissue for examination by removing any calcium present | 53 | $674 | $12 |
| Pathology examination of tissue using a microscope, moderately low complexity | 52 | $617 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 119 | $495 | $4 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $374 | $25 |
| Special stained specimen slides to examine tissue including interpretation and report | 11 | $191 | $11 |
2020: 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 173 | $22,659 | $63 |
| Pathology examination of tissue using a microscope, intermediate complexity | 218 | $13,141 | $35 |
| Evaluation of fine needle aspirate with interpretation and report | 19 | $4,784 | $159 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 20 | $3,429 | $171 |
| Special stained specimen slides to examine tissue, each additional procedure | 28 | $3,243 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 17 | $2,004 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 52 | $1,983 | $34 |
| Evaluation of fine needle aspirate with interpretation and report | 20 | $1,437 | $68 |
| Cell examination of specimen, selective cellular enhancement technique | 38 | $1,038 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 13 | $910 | $70 |
| Evaluation of fine needle aspirate | 20 | $734 | $35 |
| Pathology examination of tissue using a microscope, limited examination | 45 | $202 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 17 | $197 | $11 |
| Preparation of tissue for examination by removing any calcium present | 16 | $191 | $12 |
2019: 26 services
| Pathology examination of tissue using a microscope, intermediate complexity | 702 | $90,107 | $64 |
| Evaluation of fine needle aspirate with interpretation and report | 116 | $23,955 | $154 |
| Pathology examination of tissue using a microscope, intermediate complexity | 243 | $14,757 | $35 |
| Protein measurement, serum | 377 | $7,322 | $17 |
| Pathology examination of tissue using a microscope, moderately high complexity | 16 | $7,204 | $195 |
| Special stained specimen slides to examine tissue, each additional procedure | 24 | $6,711 | $95 |
| Cell examination of specimen, selective cellular enhancement technique | 83 | $6,525 | $68 |
| Special stained specimen slides to examine tissue, initial procedure | 42 | $6,029 | $110 |
| Pathology examination of tissue using a microscope, moderately high complexity | 34 | $4,169 | $79 |
| Immunologic analysis technique on serum (immunofixation) | 192 | $3,501 | $17 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,335 | $167 |
| Protein measurement, body fluid | 122 | $2,063 | $17 |
| Special stained specimen slides to examine tissue, each additional procedure | 15 | $1,978 | $27 |
| Evaluation of fine needle aspirate with interpretation and report | 21 | $1,535 | $67 |
| Cell examination of specimen, selective cellular enhancement technique | 49 | $1,385 | $26 |
| Pathology examination of tissue using a microscope, moderately low complexity | 26 | $1,233 | $41 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | $1,202 | $33 |
| Evaluation of fine needle aspirate | 20 | $753 | $34 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 40 | $720 | $17 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 18 | $703 | $39 |
| Protein measurement, serum | 26 | $519 | $17 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 17 | $490 | $29 |
| Immunologic analysis technique on serum (immunofixation) | 23 | $402 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 76 | $313 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 19 | $213 | $11 |
| Preparation of tissue for examination by removing any calcium present | 16 | $186 | $12 |
2018: 25 services
| Pathology examination of tissue using a microscope, intermediate complexity | 625 | $92,546 | $65 |
| Evaluation of fine needle aspirate with interpretation and report | 108 | $23,065 | $155 |
| Pathology examination of tissue using a microscope, intermediate complexity | 285 | $16,466 | $35 |
| Protein measurement, serum | 508 | $10,059 | $16 |
| Special stained specimen slides to examine tissue, initial procedure | 62 | $7,737 | $109 |
| Special stained specimen slides to examine tissue, each additional procedure | 28 | $7,071 | $91 |
| Cell examination of specimen, selective cellular enhancement technique | 81 | $6,481 | $68 |
| Immunologic analysis technique on serum (immunofixation) | 262 | $5,007 | $16 |
| Evaluation of fine needle aspirate with interpretation and report | 36 | $3,024 | $67 |
| Protein measurement, body fluid | 176 | $2,956 | $16 |
| Microscopic genetic analysis of tumor, manual | 14 | $2,836 | $129 |
| Special stained specimen slides to examine tissue, each additional procedure | 29 | $2,603 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 16 | $2,133 | $79 |
| Cell examination of specimen, selective cellular enhancement technique | 73 | $2,011 | $25 |
| Special stained specimen slides to examine tissue, initial procedure | 46 | $1,940 | $33 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 11 | $1,833 | $167 |
| Evaluation of fine needle aspirate | 36 | $1,542 | $34 |
| Pathology examination of tissue using a microscope, moderately low complexity | 32 | $1,474 | $41 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 57 | $1,085 | $16 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 27 | $1,060 | $39 |
| Microscopic genetic analysis of tumor, manual | 12 | $1,053 | $42 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 25 | $802 | $32 |
| Evaluation of fine needle aspirate | 12 | $736 | $57 |
| Pathology examination of tissue using a microscope, limited examination | 86 | $346 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 18 | $196 | $11 |
2017: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 540 | $68,343 | $61 |
| Evaluation of fine needle aspirate with interpretation and report | 127 | $26,851 | $150 |
| Pathology examination of tissue using a microscope, intermediate complexity | 259 | $14,312 | $36 |
| Pathology examination of tissue using a microscope, moderately high complexity | 20 | $11,323 | $270 |
| Protein measurement, serum | 496 | $9,688 | $16 |
| Cell examination of specimen, selective cellular enhancement technique | 114 | $8,945 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 35 | $5,180 | $106 |
| Special stained specimen slides to examine tissue, each additional procedure | 17 | $5,026 | $91 |
| Immunologic analysis technique on serum (immunofixation) | 268 | $4,828 | $16 |
| Protein measurement, body fluid | 183 | $3,136 | $17 |
| Special stained specimen slides to examine tissue, each additional procedure | 23 | $2,749 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 21 | $2,036 | $78 |
| Cell examination of specimen, selective cellular enhancement technique | 70 | $1,912 | $25 |
| Evaluation of fine needle aspirate with interpretation and report | 26 | $1,880 | $65 |
| Special stained specimen slides to examine tissue, initial procedure | 45 | $1,646 | $34 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 41 | $1,604 | $39 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 41 | $1,460 | $36 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 62 | $1,082 | $17 |
| Evaluation of fine needle aspirate | 23 | $861 | $33 |
| Pathology examination of tissue using a microscope, moderately low complexity | 15 | $755 | $42 |
| Pathology examination of tissue using a microscope, limited examination | 71 | $300 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 24 | $274 | $11 |
2016: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 489 | $66,584 | $68 |
| Evaluation of fine needle aspirate with interpretation and report | 99 | $20,441 | $151 |
| Pathology examination of tissue using a microscope, moderately high complexity | 18 | $13,613 | $317 |
| Protein measurement, serum | 442 | $9,079 | $17 |
| Pathology examination of tissue using a microscope, intermediate complexity | 154 | $8,650 | $36 |
| Cell examination of specimen, selective cellular enhancement technique | 88 | $6,981 | $69 |
| Special stained specimen slides to examine tissue, each additional procedure | 17 | $5,911 | $88 |
| Special stained specimen slides to examine tissue, initial procedure | 41 | $5,654 | $99 |
| Immunologic analysis technique on serum (immunofixation) | 267 | $4,832 | $17 |
| Protein measurement, body fluid | 134 | $2,341 | $17 |
| Cell examination of specimen, selective cellular enhancement technique | 47 | $1,290 | $25 |
| Pathology examination of tissue using a microscope, moderately high complexity | 15 | $1,277 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 31 | $1,148 | $34 |
| Evaluation of fine needle aspirate with interpretation and report | 16 | $1,080 | $67 |
| Pathology examination of tissue using a microscope, moderately low complexity | 20 | $1,053 | $46 |
| Special stained specimen slides to examine tissue, each additional procedure | 12 | $1,042 | $25 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 44 | $803 | $17 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 17 | $663 | $39 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 17 | $601 | $35 |
| Evaluation of fine needle aspirate | 14 | $485 | $35 |
| Pathology examination of tissue using a microscope, moderately low complexity | 23 | $276 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 37 | $151 | $4 |
2015: 21 services
| Pathology examination of tissue using a microscope, intermediate complexity | 717 | $110,226 | $72 |
| Evaluation of fine needle aspirate with interpretation and report | 103 | $21,366 | $155 |
| Pathology examination of tissue using a microscope, moderately high complexity | 23 | $16,656 | $327 |
| Cell examination of specimen, selective cellular enhancement technique | 93 | $7,060 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 66 | $6,846 | $94 |
| Special stained specimen slides to examine tissue, each additional procedure | 32 | $6,337 | $70 |
| Protein measurement, serum | 269 | $5,497 | $17 |
| Immunologic analysis technique on serum (immunofixation) | 183 | $3,291 | $17 |
| Pathology examination of tissue using a microscope, intermediate complexity | 53 | $2,922 | $36 |
| Pathology examination of tissue using a microscope, moderately low complexity | 34 | $1,894 | $47 |
| Protein measurement, body fluid | 80 | $1,402 | $17 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 22 | $931 | $40 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 22 | $813 | $35 |
| Evaluation of fine needle aspirate with interpretation and report | 11 | $795 | $66 |
| Cell examination of specimen, selective cellular enhancement technique | 27 | $780 | $26 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 43 | $745 | $16 |
| Evaluation of fine needle aspirate | 11 | $410 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 11 | $400 | $33 |
| Protein measurement, serum | 19 | $387 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 12 | $176 | $13 |
| Pathology examination of tissue using a microscope, limited examination | 24 | $102 | $4 |
2014: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 385 | $54,924 | $66 |
| Evaluation of fine needle aspirate with interpretation and report | 49 | $10,166 | $143 |
| Protein measurement, serum | 330 | $6,311 | $16 |
| Cell examination of specimen, selective cellular enhancement technique | 70 | $4,756 | $62 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 25 | $4,047 | $88 |
| Immunologic analysis technique on serum (immunofixation) | 218 | $3,923 | $16 |
| Pathology examination of tissue using a microscope, intermediate complexity | 61 | $3,639 | $35 |
| Protein measurement, body fluid | 122 | $2,150 | $17 |
| Protein measurement, serum | 43 | $863 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 18 | $767 | $43 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 44 | $745 | $17 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 18 | $669 | $37 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 18 | $638 | $35 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 18 | $579 | $28 |
| Cell examination of specimen, selective cellular enhancement technique | 12 | $306 | $25 |
| Immunologic analysis technique on serum (immunofixation) | 17 | $288 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $244 | $14 |
| Protein measurement, body fluid | 13 | $237 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 11 | $112 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 17 | $73 | $4 |
2013: 8 services
| Protein measurement, serum | 394 | $7,875 | $17 |
| Immunologic analysis technique on serum (immunofixation) | 218 | $4,386 | $18 |
| Pathology examination of tissue using a microscope, intermediate complexity | 52 | $2,580 | $33 |
| Protein measurement, body fluid | 96 | $1,867 | $18 |
| Cell examination of specimen, selective cellular enhancement technique | 15 | $755 | $50 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 35 | $648 | $18 |
| Protein measurement, serum | 26 | $459 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 12 | $47 | $4 |
Medicaid work
$1,075 in 2024
Medicaid paid $1,075 for 55 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 13 | $497 |
| Immunofixation electrophoresis; serum | 12 | $361 |
| PROTEIN ELECTROPHORETIC FRACTJ&QUANTJ SERUM | 30 | $216 |
| 2024 | 55 | 3 | 17 | $1,075 |
| 2023 | 26 | 1 | 14 | $1,489 |
| 2021 | 70 | 1 | 29 | $1,851 |
| 2020 | 30 | 1 | 13 | $981 |
| 2019 | 14 | 1 | 14 | $8 |
| 2018 | 44 | 3 | 15 | $1,189 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 26 | $1,489 |
2021
| TISSUE EXAM BY PATHOLOGIST | 70 | $1,851 |
2020
| TISSUE EXAM BY PATHOLOGIST | 30 | $981 |
2019
| PROTEIN ELECTROPHORETIC FRACTJ&QUANTJ SERUM | 14 | $8 |
2018
| TISSUE EXAM BY PATHOLOGIST | 15 | $1,179 |
| PROTEIN ELECTROPHORETIC FRACTJ&QUANTJ SERUM | 15 | $6 |
| Immunofixation electrophoresis; serum | 14 | $4 |
Money from drug and device companies
$106 in 2025
| 2025 | 3 | 4 | None | $106 |
| 2022 | 2 | 2 | None | $33 |
| 2020 | 1 | 1 | None | $105 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | None | $49 | 2 payments
|
| Hologic Sales and Service | Aptima | $32 | 1 payment
|
| Abbott Laboratories | I-Stat | $25 | 1 payment
|
See all 4 published payments
| Abbott Laboratories | Meals · 2025-06-04 | I-Stat | $25 |
| Amgen | Meals · 2025-04-23 | None | $24 |
| Amgen | Meals · 2025-04-23 | None | $24 |
| Hologic Sales and Service | Meals · 2025-04-22 | Aptima | $32 |
See earlier years (2022, 2020)
2022: $33
| Roche Diagnostics | Eplex | $21 | 1 payment
|
| Genentech USA | None | $12 | 1 payment
|
2020: $105
| Stemline Therapeutics | Elzonris | $105 | 1 payment
|
Professional record
- NPI
- 1124040787
- Licence
- CA G79181California G79181: Current · expires 2028-03-31
- Trained
- University of Colorado School of Medicine, Denver, 1992
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G791810
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 383 E Grand Ave, Suite A, South San Francisco, CA, 94080
- NPI first listed
- 2006-07-24
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.